Battelle, Columbus, OH, United States of America.
Non-Clinical Advisor for Joint Program Manager Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), Fort Detrick, MD, United States of America.
PLoS One. 2021 Jul 2;16(7):e0252874. doi: 10.1371/journal.pone.0252874. eCollection 2021.
Filoviruses (Family Filoviridae genera Ebolavirus and Marburgvirus) are negative-stranded RNA viruses that cause severe health effects in humans and non-human primates, including death. Except in outbreak settings, vaccines and other medical countermeasures against Ebola virus (EBOV) will require testing under the FDA Animal Rule. Multiple vaccine candidates have been evaluated using cynomolgus monkeys (CM) exposed to EBOV Kikwit strain. To the best of our knowledge, however, animal model development data supporting the use of CM in vaccine research have not been submitted to the FDA. This study describes a large CM database (122 CM, 62 female and 60 male, age 2 to 9 years) and demonstrates the consistency of the CM model through time to death models and descriptive statistics. CMs were exposed to EBOV doses of 0.1 to 100,000 PFU in 33 studies conducted at three Animal Biosafety Level 4 facilities, by three exposure routes. Time to death was modeled using Cox proportional hazards models with a frailty term that incorporated study-to-study variability. Despite significant differences attributed to exposure variables, all CMs exposed to the 100 to 1,000 pfu doses commonly used in vaccine studies died or met euthanasia criteria within 21 days of exposure, median 7 days, 93% between 5 and 12 days of exposure. Moderate clinical signs were observed 4 to 5 days after exposure and preceded death or euthanasia by approximately one day. Viremia was detected within a few days of infection. Hematology indices were indicative of viremia and the propensity for hemorrhage with progression of Ebola viremia. Changes associated with coagulation parameters and platelets were consistent with coagulation disruption. Changes in leukocyte profiles were indicative of an acute inflammatory response. Increased liver enzymes were observed shortly after exposure. Taken together, these factors suggest that the cynomolgus monkey is a reliable animal model for human disease.
丝状病毒(丝状病毒科病毒属埃博拉病毒和马尔堡病毒)是一种负链 RNA 病毒,可导致人类和非人类灵长类动物出现严重的健康影响,包括死亡。除了在疫情爆发环境下,针对埃博拉病毒(EBOV)的疫苗和其他医疗对策都需要根据 FDA 的动物规则进行测试。已经使用食蟹猴(CM)评估了多种疫苗候选物,这些 CM 接触了埃博拉病毒 Kikwit 株。据我们所知,支持在疫苗研究中使用 CM 的动物模型开发数据尚未提交给 FDA。本研究描述了一个大型 CM 数据库(122 只 CM,62 只雌性,60 只雄性,年龄 2 至 9 岁),并通过时间至死亡模型和描述性统计数据证明了 CM 模型的一致性。在三个动物生物安全 4 级设施中进行的 33 项研究中,通过三种暴露途径,用 0.1 至 100,000 PFU 的 EBOV 剂量对 CM 进行了暴露。使用包含研究间变异性的 frailty 项的 Cox 比例风险模型对死亡时间进行建模。尽管由于暴露变量而存在显著差异,但所有暴露于 100 至 1,000 pfu 剂量的 CM 通常用于疫苗研究,在暴露后 21 天内死亡或达到安乐死标准,中位数为 7 天,93%在暴露后 5 至 12 天内死亡。中度临床症状在暴露后 4 至 5 天观察到,死亡或安乐死前约 1 天。在感染后几天内检测到病毒血症。血液学指标提示病毒血症和随着埃博拉病毒血症的进展发生出血的倾向。与凝血参数和血小板相关的变化与凝血障碍一致。白细胞谱的变化提示急性炎症反应。暴露后不久观察到肝酶升高。总之,这些因素表明食蟹猴是人类疾病的可靠动物模型。